These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38124763)

  • 1. Temporal trends in laboratory parameters in survivors and non‑survivors of critical COVID‑19 illness and the effect of dexamethasone treatment.
    Kokkoris S; Kanavou A; Katsaros D; Karageorgiou S; Kremmydas P; Gkoufa A; Ntaidou T; Giannopoulos C; Kardamitsi MA; Dimopoulou G; Theodorou E; Georgakopoulou VE; Spandidos DA; Orfanos S; Kotanidou A; Routsi C
    Biomed Rep; 2024 Jan; 20(1):12. PubMed ID: 38124763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal evolution of laboratory characteristics in patients critically ill with COVID‑19 admitted to the intensive care unit (Review).
    Kokkoris S; Kanavou A; Kremmydas P; Katsaros D; Karageorgiou S; Gkoufa A; Georgakopoulou VE; Spandidos DA; Giannopoulos C; Kardamitsi M; Routsi C
    Med Int (Lond); 2023; 3(5):52. PubMed ID: 37810906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.
    Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A
    Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971
    [No Abstract]   [Full Text] [Related]  

  • 4. Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19.
    Ouyang SM; Zhu HQ; Xie YN; Zou ZS; Zuo HM; Rao YW; Liu XY; Zhong B; Chen X
    BMC Infect Dis; 2020 Dec; 20(1):952. PubMed ID: 33308159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Profile of Prognostic Hematologic Indicators in Patient Under Intensive Care for COVID-19 Disease: A One-Year Study at a Tertiary Care Centre in South India.
    Balasubramanian J; Suman FR; Stephen IR; Shanmugam SG; Mani R; Mathan B; P L
    Cureus; 2021 Nov; 13(11):e19585. PubMed ID: 34926056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship of Hematological Parameters and C-reactive Protein (CRP) With Disease Presence, Severity, and Response to Systemic Therapy in Patients With Psoriasis.
    Şener G; İnan Yuksel E; Gökdeniz O; Karaman K; Canat HD
    Cureus; 2023 Aug; 15(8):e43790. PubMed ID: 37731441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution.
    Sepulchre E; Pittie G; Stojkovic V; Haesbroek G; Crama Y; Schyns M; Paridaens H; de Marchin J; Degesves S; Biemar C; Boccar S; Senterre JM; Minon JM
    Acta Clin Belg; 2022 Apr; 77(2):261-267. PubMed ID: 32935644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the predictive values of procalcitonin/albumin ratio and other inflammatory markers in determining COVID-19 severity.
    Çakırca TD; Çakırca G; Torun A; Bindal A; Üstünel M; Kaya A
    Pak J Med Sci; 2023; 39(2):450-455. PubMed ID: 36950410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes in routine blood parameters of a severe COVID-19 case.
    Lu G; Wang J
    Clin Chim Acta; 2020 Sep; 508():98-102. PubMed ID: 32405079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can COVID-19 Mortality be Predicted in the Emergency Room?
    Güneysu F; Guner NG; Erdem AF; Durmus E; Durgun Y; Yurumez Y
    J Coll Physicians Surg Pak; 2020 Sep; 30(9):928-932. PubMed ID: 33036676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine laboratory parameters in estimating mortality and morbidity in COVID-19 diagnosed cases followed in the intensive care unit.
    Kutlusoy S; Koca E
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5885-5892. PubMed ID: 37401326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A biological profile for diagnosis and outcome of COVID-19 patients.
    Khourssaji M; Chapelle V; Evenepoel A; Belkhir L; Yombi JC; van Dievoet MA; Saussoy P; Coche E; Fillée C; Constantinescu SN; Rodriguez-Villalobos H; Defour JP; Gruson D
    Clin Chem Lab Med; 2020 Oct; 58(12):2141-2150. PubMed ID: 33064667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The İmportance of hematological parameters in the prognosis of patients with severe COVID-19, A single-center retrospective study.
    Gozukucuk R; Kılıc HH; Uyanik BS; Cakiroglu B
    Niger J Clin Pract; 2023 Sep; 26(9):1297-1302. PubMed ID: 37794542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in ICU COVID-19 Patients Is Associated with Neutrophil-to-Lymphocyte Ratio (NLR): Utility of NLR as a Promising Immunohematological Marker.
    Seyfi S; Azadmehr A; Ezoji K; Nabipour M; Babazadeh A; Saleki K; Mahmoodi M; Pouladi AH
    Interdiscip Perspect Infect Dis; 2023; 2023():9048749. PubMed ID: 38025794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil to lymphocyte ratio as a predictor of treatment response and mortality in septic shock patients in the intensive care unit.
    Sarı R; Karakurt Z; Ay M; Çelik ME; Yalaz Tekan Ü; Çiyiltepe F; Kargın F; Saltürk C; Yazıcıoğlu Moçin Ö; Güngör G; Adıgüzel N
    Turk J Med Sci; 2019 Oct; 49(5):1336-1349. PubMed ID: 31648506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte-C-reactive protein ratio can differentiate disease severity of COVID-19 patients and serve as an assistant screening tool for hospital and ICU admission.
    Zhang JN; Gao Y; Wang XT; Li NN; Du X; Tang YJ; Lai QQ; Chen PF; Yue CS; Wu JH; Kang K; Zhao MY
    Front Immunol; 2022; 13():957407. PubMed ID: 36248811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-Dependent Changes of Laboratory Parameters as Independent Predictors of All-Cause Mortality in COVID-19 Patients.
    Limon-de la Rosa N; Cervantes-Alvarez E; Méndez-Guerrero O; Gutierrez-Gallardo MA; Kershenobich D; Navarro-Alvarez N
    Biology (Basel); 2022 Apr; 11(4):. PubMed ID: 35453779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between platelet indices and the severity of the disease and mortality in patients with COVID-19.
    Yardımcı AC; Yıldız S; Ergen E; Ballı H; Ergene E; Guner YS; Karnap M; Demırbas Keskın D; Yuksel H; Bocutoglu F; Akbel VC; Kalyoncu D
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6731-6740. PubMed ID: 34787878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil count, lymphocyte count and neutrophil-to-lymphocyte ratio in relation to response to adjunctive dexamethasone treatment in community-acquired pneumonia.
    Wittermans E; van de Garde EM; Voorn GP; Aldenkamp AF; Janssen R; Grutters JC; Bos WJW;
    Eur J Intern Med; 2022 Feb; 96():102-108. PubMed ID: 34782191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.